OPEN Foundation

Perceptions of the medicinal value of hallucinogenic drugs among college students

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Abstract

Background

This survey examined perceptions among college students about the potential medicinal benefits of hallucinogenic drugs. Current research and potential benefits include an ability to help anxiety, post-traumatic stress disorder, and addiction with hallucinogen-assisted psychotherapy.

Methods

We devised and administered a survey on 124 students at two college campuses, one small private college in the mid-Atlantic and one medium-sized public university in the Midwest of the United States.

Results

Responses were similar across campuses, and in general, participants were reluctant to agree that hallucinogens can be therapeutic to the seven afflictions we questioned them about. However, the survey also revealed that a majority of participants believed there should be further research done exploring the medicinal benefits of such drugs.

Conclusion

These findings shed light on perceptions of hallucinogens as their use is being applied to a host of afflictions.

Wildberger, J. I., John, C. N., & Hallock, R. M. (2017). Perceptions of the medicinal value of hallucinogenic drugs among college students. Journal of Psychedelic Studies, (0), 1-5. 10.1556/2054.01.2017.008
Link to full text

OPEN Foundation

Join ICPR 2022 Online!

ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. Get your ICPR 2022 livestream ticket today and use the code OPENLIVE30 at checkout for a €30 discount.

Learn More

INTERESTED IN PSYCHEDELIC RESEARCH AND THERAPIES?

Subscribe to our new OPEN-Minded newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

30 April - Q&A with Rick Strassman

X